Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Meikle, Peter J ^a   Wong, Gerard ^a   Barlow, Christopher K ^a   Weir, Jacquelyn M ^a   Greeve, Melissa A ^a   MacIntosh, Gemma L ^a   Almasy, Laura ^b   Comuzzie, Anthony G ^b   Mahaney, Michael C ^b   Kowalczyk, Adam ^c   Haviv, Izhac ^a   Grantham, Narelle ^a   Magliano, Dianna J ^a   Jowett, Jeremy B M ^a   Zimmet, Paul ^a   Curran, Joanne E ^b   Blangero, John ^b   Shaw, Jonathan ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENYLPHOSPHATIDYLCHOLINE; ALKYLPHOSPHATIDYLCHOLINE; CERAMIDE; CERAMIDE DIHEXOSIDE; CHOLESTEROL ESTER; DIACYLGLYCEROL; DIHYDROCERAMIDE; GLUCOSE; GLYCEROLIPID; HEMOGLOBIN A1C; INSULIN; LIPID; LIPIDOME; LYSOALKYLPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; SPHINGOLIPID; SPHINGOMYELIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPIDOMICS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 84884678009     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074341     Document Type: Article

References (39)

1. Magliano DJ, Shaw JE, Shortreed SM, Nusselder WJ, Liew D, et al. (2008) Lifetime risk and projected population prevalence of diabetes. Diabetologia 51: 2179-2186.
2. Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, et al. (2009) Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58: 337-343.
3. Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, et al. (2011) Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 31: 2723-2732.
4. Kaddurah-Daouk R, Baillie RA, Zhu H, Zeng ZB, Wiest MM, et al. (2010) Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study. Metabolomics 6: 191-201.
5. Huo T, Cai S, Lu X, Sha Y, Yu M, et al. (2009) Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride. J Pharm Biomed Anal 49: 976-982.
6. Han L-D, Xia J-F, Liang Q-L, Wang Y, Wang Y-M, et al. (2011) Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy. Analytica Chimica Acta 689: 85-91.
7. Liu G, Han F, Yang Y, Xie Y, Jiang H, et al. (2011) Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin. Nephrology Dialysis Transplantation 26: 1493-1502.
8. Zhu C, Liang Q-l, Hu P, Wang Y-m, Luo G-a, (2011) Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy. Talanta 85: 1711-1720.
9. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, et al. (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates. Diabetes Res Clin Pract 57: 119-129.
10. Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, et al. (1996) Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 94: 2159-2170.
11. Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, et al. (2011) Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 60: 1458-1466.
12. Boslem E, MacIntosh G, Preston AM, Bartley C, Busch AK, et al. (2011) A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem J 435: 267-276.
13. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
14. Drew BG, Carey AL, Natoli AK, Formosa MF, Vizi D, et al. (2011) Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus. J Lipid Res 52: 572-581.
15. Murphy RC, James PF, McAnoy AM, Krank J, Duchoslav E, et al. (2007) Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry. Anal Biochem 366: 59-70.
16. Tandy S, Chung RW, Kamili A, Wat E, Weir JM, et al. (2010) Hydrogenated phosphatidylcholine supplementation reduces hepatic lipid levels in mice fed a high-fat diet. Atherosclerosis 213: 142-147.
17. Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, et al. (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29: 1909-1914.
18. Riebeling C, Allegood JC, Wang E, Merrill AH Jr, Futerman AH, (2003) Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem 278: 43452-43459.
19. Frangioudakis G, Garrard J, Raddatz K, Nadler JL, Mitchell TW, et al. (2010) Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors. Endocrinology 151: 4187-4196.
20. Stiban J, Tidhar R, Futerman AH, (2010) Ceramide synthases: roles in cell physiology and signaling. Adv Exp Med Biol 688: 60-71.
21. Xu Z, Zhou J, McCoy DM, Mallampalli RK, (2005) LASS5 is the predominant ceramide synthase isoform involved in de novo sphingolipid synthesis in lung epithelia. J Lipid Res 46: 1229-1238.
22. Adiels M, Boren J, Caslake MJ, Stewart P, Soro A, et al. (2005) Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 25: 1697-1703.
23. Sciacca MF, Brender JR, Lee DK, Ramamoorthy A, (2012) Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation. Biochemistry 51: 7676-7684.
24. Hodge AM, Simpson JA, Gibson RA, Sinclair AJ, Makrides M, et al. (2007) Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutr Metab Cardiovasc Dis 17: 415-426.
25. Wolk A, Furuheim M, Vessby B, (2001) Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr 131: 828-833.
26. Elwood PC, Pickering JE, Givens DI, Gallacher JE, (2010) The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45: 925-939.
27. Grantham NM, Magliano DJ, Hodge A, Jowett J, Meikle P, et al. (2012) The association between dairy food intake and the incidence of diabetes in Australia: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Public Health Nutr: 1-7.
28. Villegas R, Gao YT, Dai Q, Yang G, Cai H, et al. (2009) Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study. Am J Clin Nutr 89: 1059-1067.
29. Kroger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, et al. (2011) Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 93: 127-142.
30. Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw KT, et al. (2010) Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 92: 1214-1222.
31. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, et al. (2010) Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 153: 790-799.
32. Ford DA, (2010) Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia. Clin Lipidol 5: 835-852.
33. Skaff O, Pattison DI, Davies MJ, (2008) The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study. Biochemistry 47: 8237-8245.
34. Lessig J, Fuchs B, (2009) Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis. Curr Med Chem 16: 2021-2041.
35. Wallner S, Schmitz G, (2011) Plasmalogens the neglected regulatory and scavenging lipid species. Chem Phys Lipids 164: 573-589.
36. Nelson TL, Biggs ML, Kizer JR, Cushman M, Hokanson JE, et al. (2012) Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study. J Clin Endocrinol Metab 97: 1695-1701.
37. Serban M, Tanaseanu C, Kosaka T, Vidulescu C, Stoian I, et al. (2002) Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus. J Cell Mol Med 6: 643-647.
38. Sanchez-Quesada JL, Vinagre I, de Juan-Franco E, Sanchez-Hernandez J, Blanco-Vaca F, et al. (2012) Effect of improving glycemic control in patients with type 2 diabetes mellitus on low-density lipoprotein size, electronegative low-density lipoprotein and lipoprotein-associated phospholipase A2 distribution. Am J Cardiol 110: 67-71.
39. Fan P, Liu H, Wang Y, Zhang F, Bai H, (2012) Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS. Reprod Biomed Online 24: 197-205.